Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Nephrotoxicity

  • You have access
    Effect of Ganoderma lucidum on Cisplatin-induced Nephrotoxicity and Gastrointestinal Toxicity
    NATSUKI OTA, SHOYA ENDO, RYOSUKE TATSUNAMI, AOI YAMAGUCHI, KOJI WAKAME, AKIFUMI NAKATA and KEISUKE SATO
    Anticancer Research August 2024, 44 (8) 3605-3613; DOI: https://doi.org/10.21873/anticanres.17183
  • You have access
    Suitability of Oral Rehydration Solution (ORS) for Use in the Cisplatin Short Hydration Method
    YOSHITAKA SAITO, YOH TAKEKUMA, MASAKI KOBAYASHI, NAOFUMI SHINAGAWA, TAKURO NOGUCHI, SATOSHI TAKEUCHI, YASUSHI SHIMIZU, ICHIRO KINOSHITA, HIROTOSHI DOSAKA-AKITA and MITSURU SUGAWARA
    Anticancer Research June 2022, 42 (6) 3185-3193; DOI: https://doi.org/10.21873/anticanres.15808
  • You have access
    Non-steroidal Anti-inflammatory Drugs Are a Risk Factor for Cisplatin-induced Nephrotoxicity: A Meta-analysis of Retrospective Studies
    KEISUKE OKAMOTO, YOSHITAKA SAITO, KATSUYA NARUMI, AYAKO FURUGEN, KEN ISEKI and MASAKI KOBAYASHI
    Anticancer Research March 2020, 40 (3) 1747-1751; DOI: https://doi.org/10.21873/anticanres.14128
  • You have access
    Hydration with 15 mEq Magnesium Is Effective at Reducingthe Risk for Cisplatin-induced Nephrotoxicity in Patients Receiving Cisplatin (≥50 mg/m2) Combination Chemotherapy
    YOSHIHIRO YAMAMOTO, KAZUSHI WATANABE, IKUTO TSUKIYAMA, HIROMITSU YABUSHITA, KATSUHIKO MATSUURA and AKIHIKO WAKATSUKI
    Anticancer Research April 2016, 36 (4) 1873-1877;
  • You have access
    Nephroprotective Effects of Hydration with Magnesium in Patients with Cervical Cancer Receiving Cisplatin
    YOSHIHIRO YAMAMOTO, KAZUSHI WATANABE, IKUTO TSUKIYAMA, HIROSHI MATSUSHITA, HIROMITSU YABUSHITA, KATSUHIKO MATSUURA and AKIHIKO WAKATSUKI
    Anticancer Research April 2015, 35 (4) 2199-2204;
  • You have access
    Lack of Difference in Acute Nephrotoxicity of Intravenous Bisphosphonates Zoledronic Acid and Ibandronate in Women with Breast Cancer and Bone Metastases
    DÖRTE W. LUEDDERS, JÜRGEN STEINHOFF, MARC THILL, ACHIM RODY and MICHAEL K. BOHLMANN
    Anticancer Research March 2015, 35 (3) 1797-1802;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire